Treatment of Primary Immune Thrombocytopenia with Thrombopoietin Receptor Agonists: Effect On Platelet Function and Plasma Thrombin Generation

被引:0
|
作者
Fernandez Bello, Ihosvany [1 ]
Jimenez Yuste, Victor [1 ]
Alvarez Roman, Mayte [1 ]
Martin Salces, Monica [1 ]
Canales, Miguel
Butta, Nora V. [1 ]
机构
[1] Hosp Univ La Paz, IDIPaz, Madrid, Spain
关键词
D O I
10.1182/blood.V120.21.1089.1089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1089
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
    Evangelidis, Paschalis
    Tragiannidis, Konstantinos
    Gavriilaki, Eleni
    Tragiannidis, Athanasios
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (01)
  • [32] TREATMENT PATTERNS PRIOR TO THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA IN GERMANY
    Schill, M.
    Taieb, V
    Richter, H.
    Lebioda, A.
    VALUE IN HEALTH, 2020, 23 : S715 - S715
  • [33] Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in children
    Nolla, Marie
    Aladjidi, Nathalie
    Leblanc, Thierry
    Fernandes, Helder
    Ducassou, Stephane
    Fahd, Mony
    Barlogis, Vincent
    Michel, Marc
    Blouin, Pascale
    Jeziorski, Eric
    Benadiba, Joy
    Pondarre, Corinne
    Leverger, Guy
    Pasquet, Marlene
    BLOOD, 2021, 137 (01) : 138 - 141
  • [34] EFFECT OF THROMBOPOIETIN-RECEPTOR AGONISTS ON CIRCULATING CYTOKINE AND CHEMOKINE LEVELS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
    Gudbrandsdottir, S.
    Ghanima, W.
    Feng, X.
    Lee, S.
    Nielsen, C.
    Hasselbalch, H.
    Bussel, J.
    HAEMATOLOGICA, 2012, 97 : 199 - 200
  • [35] Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP)
    Gudbrandsdottir, Sif
    Ghanima, Waleed
    Nielsen, Claus H.
    Feng, Xingmin
    Hasselbalch, Hans C.
    Bussel, James
    PLATELETS, 2017, 28 (05) : 478 - 483
  • [37] Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia
    Palandri, Francesca
    Rossi, Elena
    Bartoletti, Daniela
    Ferretti, Antonietta
    Ruggeri, Marco
    Lucchini, Elisa
    Carrai, Valentina
    Barcellini, Wilma
    Patriarca, Andrea
    Rivolti, Elena
    Consoli, Ugo
    Cantoni, Silvia
    Oliva, Esther Natalie
    Chiurazzi, Federico
    Caocci, Giovanni
    Giuffrida, Gaetano
    Borchiellini, Alessandra
    Auteri, Giuseppe
    Baldacci, Erminia
    Carli, Giuseppe
    Nicolosi, Daniela
    Sutto, Emanuele
    Carpenedo, Monica
    Cavo, Michele
    Mazzucconi, Maria Gabriella
    Zaja, Francesco
    De Stefano, Valerio
    Rodeghiero, Francesco
    Vianelli, Nicola
    BLOOD, 2021, 138 (07) : 571 - 583
  • [38] Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia
    Mitchell, William Beau
    Pinheiro, Mariana P.
    Boulad, Nayla
    Kaplan, David
    Edison, Michele N.
    Psaila, Bethan
    Karpoff, Marissa
    White, Michael J.
    Josefsson, Emma C.
    Kile, Benjamin T.
    Bussel, James B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (12) : E228 - E234
  • [39] Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice
    Ptushkin, V. V.
    Vinogradova, O. Yu.
    Pankrashkina, M. M.
    Chernikov, M. V.
    Arshanskaya, E. G.
    Tkachenko, N. E.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (07) : 70 - 76
  • [40] The role of thrombopoietin receptor agonists in the management of adult primary immune thrombocytopenia - a single center experience
    Virijevic, Marijana
    Mitrovic, Mirjana
    Pantic, Nikola
    Pravdic, Zlatko
    Sabljic, Nikica
    Suvajdzic-Vukovic, Nada
    VOJNOSANITETSKI PREGLED, 2022, 79 (10) : 958 - 962